The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
Research institutes have committed £5.5 million in funding for a world-leading research team tasked with making personalised medicines for bowel cancer patients.
Tarlatamaba, a new treatment for adult patients with small cell lung cancer (SCLC), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).
The Amplitude Consortium is thrilled to announce its final online workshop, the Amplitude Project Showcase, where the latest advancements in multi-modal imaging for bladder cancer diagnosis and therapy monitoring will be unveiled.
The NHS is looking for volunteers as part of the three cancer projects that have been selected as part of the NHS DigiTrials initiative. Almost 150,000 volunteers will take part in these trials to help transform cancer treatment.
Gareth Jenkins, a partner at Changeology Group Ltd, discusses the potential of detailed analysis to enhance the efficiency of cancer care within the NHS.
Driven by personal loss, this healthcare leader shares how their organisation (SAH Diagnostics) partners with the NHS, combining innovation and clinical excellence to reduce NHS cancer backlogs and improve patient outcomes in an exclusive interview with Open Access Government.
Asal Shirazi, Founder and CEO of the Autoimmune Support and Awareness (ASA) Foundation, discusses the increased prevalence of cancer in the UK and the challenges facing NHS England as it works to tackle backlogs in cancer care.
As the UK’s healthcare system continues to struggle with care and cancer backlogs, Gareth Jenkins of Changeology Group Ltd explains how the company can assist healthcare teams in making positive operational changes that enhance efficiency and patient outcomes.
Milena Angelova, EESC member and Rapporteur for the EESC opinion on Vaccine-preventable cancers, highlights the vital role of civil society in eradicating them.
Researchers have unveiled a pioneering method that could revolutionise the early detection of pancreatic cancer, a disease known for its late diagnosis and low survival rates.
A new study led by researchers at University College London (UCL) suggests that routine blood tests could significantly enhance early cancer diagnosis for individuals experiencing stomach pain or bloating.
New research highlights a crucial consideration for men battling prostate cancer, a potentially heightened risk of heart disease when certain medications are combined.
